Quantcast
Last updated on April 17, 2014 at 16:43 EDT

HCP Formulas Introduces Fibrenza(TM), a Natural, Ultra-Premium Systemic Enzyme Therapy Alternative Without Synthetic Chemicals

May 24, 2013

TEMPE, Ariz., May 24, 2013 /PRNewswire/ — The newly released flagship enzyme blend, Fibrenza(TM), utilizes advanced technology in a time-release capsule that offers the benefits of enteric coatings, without the use of synthetic chemicals.

(Photo: http://photos.prnewswire.com/prnh/20130524/PH20296)

Systemic enzyme use is at an all-time high, according to Heather Lewis, Brand Manager at HCP Formulas. She attributes much of the increased usage to social media. “Ten years ago, systemic enzymes were mainly considered as a natural remedy for pain and inflammation. Today, thousands of users are sharing their stories online about their enzyme therapy success for conditions associated with excess fibrin formation, detoxification, and many other chronic ailments.”

A major drawback of many of the systemic enzyme blends available has been the composition of the enteric coatings, some of which contain phthalates (plasticizers). Enteric coatings are also used in pharmaceutical drugs and are necessary to prevent stomach acids from destroying the enzymes before they are absorbed in to the bloodstream. But the chemical makeup of these coatings has made many users wary of taking systemic enzymes for prolonged periods. Fibrenza addresses this concern.

The new AcidDefenz(TM) capsule technology incorporated in Fibrenza offers the stomach acid protection provided by traditional enteric coatings, but does not contain harmful additives, solvents, or synthetic chemicals. The capsule consists of a plant-derived cellulose barrier that offers a timed-release, allowing it to pass through the stomach acids unharmed. “Our healthcare professional and retail partners are excited to be able to offer a truly natural systemic enzyme for long-term consumption,” Lewis says.

In addition to the AcidDefenz capsule, Fibrenza also introduces powerful enzymes that are not typically found in enzyme formulas due to their prohibitive cost. Superoxide dismutase, Nattokinase NSK-SD(TM), and Seaprose S(TM) contribute to the effectiveness of the new ultra-premium entry to the systemic enzyme market.

To learn more about Fibrenza from HCP Formulas, visit www.fibrenza.com.

Contact Information

HCP Formulas
Heather Lewis
2221 W. Baseline Rd. Suite 101
Tempe, AZ 85283
(800) 710-2585
Email

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.

SOURCE HCP Formulas


Source: PR Newswire